Issue 19, 2023

Expression of Concern: Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery

Abstract

Expression of Concern for ‘Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery’ by Jianxin Liu et al., Biomater. Sci., 2018, 6, 2838–2849, https://doi.org/10.1039/C8BM00726H.

Associated articles

Article information

Article type
Expression of Concern
Submitted
21 Aug 2023
Accepted
21 Aug 2023
First published
04 Sep 2023
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2023,11, 6674-6674

Expression of Concern: Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery

J. Liu, F. Xu, J. Huang, J. Xu, Y. Liu, Y. Yao, M. Ao, A. Li, L. Hao, Y. Cao, Z. Hu, H. Ran, Z. Wang and P. Li, Biomater. Sci., 2023, 11, 6674 DOI: 10.1039/D3BM90073H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements